 | |
 | |
| Names | |
|---|---|
| Preferred IUPAC name 2-Anilinobenzoic acid | |
| Other names N-phenylanthranilic acid | |
| Identifiers | |
| |
3D model (JSmol) | |
| ChEBI | |
| ChEMBL | |
| ChemSpider |
|
| ECHA InfoCard | 100.001.879 |
| UNII | |
| |
| |
| Properties | |
| C13H11NO2 | |
| Molar mass | 213.23 g/mol |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Fenamic acid is anorganic compound, which, especially in its ester form, is calledfenamate.[1]: 458 serves as a parent structure for severalnonsteroidal anti-inflammatory drugs (NSAIDs), includingmefenamic acid,tolfenamic acid,flufenamic acid, andmeclofenamic acid. These drugs are commonly referred to as "anthranilic acid derivatives" or "fenamates" because fenamic acid is a derivative ofanthranilic acid.[2]: 235 [3]: 17 [2]
Fenamic acid can be synthesized from2-chlorobenzoic acid and can be converted intoacridone.[4]
| pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams | |
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key:underline indicates initially developed first-in-class compound of specific group;#WHO-Essential Medicines;†withdrawn drugs;‡veterinary use. | |
